Acadian Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Sell |
51,640
-145,287
| -74% | -$104K | ﹤0.01% | 1517 |
|
|
2025
Q1 | $158K | Buy |
196,927
+196,556
| +52,980% | +$158K | ﹤0.01% | 1291 |
|
|
2024
Q4 | $0 | Sell |
371
-56,074
| -99% | – | ﹤0.01% | 1702 |
|
|
2024
Q3 | $58K | Buy |
+56,445
| New | +$58K | ﹤0.01% | 1754 |
|
|
2024
Q1 | – | Sell |
-592,232
| Closed | -$1.97M | – | 1592 |
|
|
2023
Q4 | $1.97M | Buy |
+592,232
| New | +$1.97M | 0.01% | 674 |
|
|
2022
Q3 | – | Sell |
-5,720
| Closed | -$41K | – | 1682 |
|
|
2022
Q2 | $41K | Buy |
+5,720
| New | +$41K | ﹤0.01% | 1527 |
|
|
2020
Q3 | – | Sell |
-87,391
| Closed | -$1.56M | – | 2191 |
|
|
2020
Q2 | $1.56M | Sell |
87,391
-107,066
| -55% | -$1.91M | 0.01% | 808 |
|
|
2020
Q1 | $3.15M | Buy |
+194,457
| New | +$3.15M | 0.02% | 481 |
|